$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
瑞戈非尼三大适应症
2025-10-19 11:44:20
Check Details
瑞戈非尼什么时候上市的?
2025-10-19 11:44:20
Check Details
瑞戈非尼使用说明
2025-10-19 11:44:20
Check Details
瑞戈非尼是哪产的呢?
2025-10-19 11:44:20
Check Details
瑞戈非尼是治疗什么病症呢?
2025-10-19 11:44:20
Check Details
瑞戈非尼需要注意什么事项?
2025-10-19 11:44:20
Check Details
瑞戈非尼一个月要多少钱?
2025-10-19 11:44:20
Check Details
瑞戈非尼治疗肝癌效果好吗?
2025-10-19 11:44:20
Check Details
瑞戈非尼治疗胃肠道间质瘤疗效好吗?
2025-10-19 11:44:20
Check Details
瑞戈非尼治疗效果如何呢?
2025-10-19 11:44:20
Check Details
瑞戈非尼治疗效果怎么样呢?
2025-10-19 11:44:20
Check Details
瑞戈非尼主治什么病症?
2025-10-19 11:44:20
Check Details
1
2
...
2759
2760
2761
2762
2763
2764
2765
...
4155
4156
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
FDA Approves Ibrance for New Maintenance Indication in HR+/HER2+ Breast Cancer
2
FDA Approves Trodelvy for Two First-Line Indications, Redefining Advanced Triple-Negative Breast Cancer Care
3
Cabozantinib: A Pan-Targeted TKI in Modern Oncology Practice
4
Managing Amivantamab Infusion Reactions: A Clinical Guide for International Practice
5
Onset Timeline and Efficacy Assessment of Margetuximab plus Chemotherapy in HER2-Positive Metastatic Breast Cancer
6
Avutometinib Plus Defactinib: A Precision Therapy for KRAS-Mutant Recurrent Low-Grade Serous Ovarian Cancer
7
Vemurafenib (Zelboraf) Complete Medication Guide
8
Durvalumab Safety Profile: Managing Immune-Related Adverse Events (irAEs) in Clinical Practice
9
Zolbetuximab Combination Therapy: Global Efficacy and Safety Profile in CLDN18.2-Positive Advanced Gastric Cancer
10
Managing Mitotane Resistance in Adrenocortical Carcinoma: Strategies and Global Options
11
Trametinib & Dabrafenib in 2026: A Global Guide to Treating BRAF-Mutant Cancers
12
A Guide to Safely Stopping Mitotane: Why Tapering is Essential and How to Manage